Scribe Therapeutics’ Post

How can we transform the standard of care for heart disease? ❤️🩹 This weekend, our CEO Benjamin Oakes will discuss promising #CRISPR gene editing and epigenetic silencing strategies at the Cardiovascular Research Foundation’s TCT MedTech Innovation Forum. Learn more about our work engineering safe and potent genetic medicines for cardiometabolic disease at #TCT2025. We’re excited to share the promise of CRISPR at the world’s premier meeting in interventional cardiovascular medicine! 📅 Saturday, October 25, 2025 at 11am PT 💡 MedTech Main Arena Session 3: Keeping an Eye on the Rearview Mirror: What Is the Next Big Disruption in Healthcare? → Genomics and Molecular Therapeutics: Engineering the Next Therapeutic Frontier 📍 Moscone Center, SF

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories